RXRX Recursion Pharmaceuticals
- 8.120
- +0.280+3.57%
- 8.290
- +0.170+2.09%
Recursion Pharmaceuticals News
Recursion Pharmaceuticals (RXRX) Declines More Than Market: Some Information for Investors
Moderna (MRNA.US) embraces the “AI+ Healthcare” wave! Join forces with OpenAI to accelerate drug development
Moderna, which is famous worldwide for its m-RNA-based COVID-19 vaccine, announced on Wednesday that the company has partnered with ChatGPT developer OpenAI.
Trending Industry Today: Arm Holdings Leads Gains In NVIDIA Holdings Stocks
April 24th - The industry of $NVIDIA Holdings(BK20882.US)$ is trending up in regular trading hours with 3 constituents up, 2 constituents down and Arm Holdings leading Gains.$Arm Holdings(ARM.US)$ up
Moderna and OpenAI in Pact to Fast-track Drug Development
Jim Cramer Says This Energy Stock Is 'Terrific,' Calls Casey's General Stores A 'Winner'
On CNBC's "Mad Money Lightning Round," Jim Cramer recommended selling Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR). "I like PBR the beer more than I like PBR the oil company," he added.Cramer rec
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersImmutep (NASDAQ:IMMP) stock increased by 15.5% to $2.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $344.7 million. Syra Health (NASDAQ:SYRA) stock
Recursion Pharmaceuticals (NASDAQ:RXRX) AI-Driven Drug Discovery Offers Promising Upside
Trending Industry Today: SoundHound AI Leads Gains In NVIDIA Holdings Stocks
April 23rd - The industry of $NVIDIA Holdings(BK20882.US)$ is trending up in regular trading hours with 4 constituents up and SoundHound AI leading Gains.$SoundHound AI(SOUN.US)$ inches up 5.55% to $3
Recursion Pharmaceuticals(RXRX.US) Director Sells US$87,725.23 in Common Stock
$Recursion Pharmaceuticals(RXRX.US)$ Director Borgeson Blake sold 11,447 shares of common stock on Apr 16, 2024 at an average price of $7.6636 for a total value of $87,725.23.Source: Announcement What
Recursion Pharmaceuticals(RXRX.US) Officer Sells US$367.01K in Common Stock
$Recursion Pharmaceuticals(RXRX.US)$ Officer Secora Michael sold 48,124 shares of common stock on Apr 16, 17, 2024 at an average price of $7.6263 for a total value of $367.01K.Source: Announcement Wha
Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing
Michael Secora, Chief Financial Officer, on April 16, 2024, sold 48,124 shares in Recursion Pharmaceuticals (RXRX) for $367,007. Following the Form 4 filing with the SEC, Secora has control over a tot
Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know
Form 144 | Recursion Pharmaceuticals(RXRX.US) Officer Proposes to Sell 175.35K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 17, $Recursion Pharmaceuticals(RXRX.US)$ Officer Secora Michael intends to sell 23,124 shares of its common stock on Apr 17, with a total market value of approximately $175
Where Will Recursion Pharmaceuticals Be in 5 Years?
Form 144(Amend) | Recursion Pharmaceuticals(RXRX.US) Officer Proposes to Sell 191.66K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 16, $Recursion Pharmaceuticals(RXRX.US)$ Officer Secora Michael intends to sell 25,000 shares of its common stock on Apr 16, with a total market value of approximately $191
Form 144 | Recursion Pharmaceuticals(RXRX.US) Officer Proposes to Sell 191.66K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 16, $Recursion Pharmaceuticals(RXRX.US)$ Officer Secora Michael intends to sell 25,000 shares of its common stock on Apr 16, with a total market value of approximately $191
Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer
Recursion Pharmaceuticals (RXRX) said Tuesday it has appointed Najat Khan as its chief R&D officer and chief commercial officer. Khan has also been appointed to the company's board. Khan previously se
Recursion Pharmaceuticals Welcomes New Director and C-Suite Executive
Express News | Recursion Appoints Najat Khan, Phd, as Chief R&D Officer and Chief Commercial Officer
Trending Industry Today: TuSimple Leads Losses In NVIDIA Holdings Stocks
April 12th - The industry of $NVIDIA Holdings(BK20882.US)$ is trending down in regular trading hours with 5 constituents down and TuSimple leading Losses.$TuSimple(TSPH.US)$ declines 13.68% to $0.41 w
Analysis
Price Target
No Data
